KEY vs LRMR · P/E 13, rev $7.51B vs $204.9M cap
KeyCorp (KEY) versus Larimar Therapeutics Inc (LRMR) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Larimar Therapeutics Inc (LRMR) is a biotechnology company listed on US.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
LRMR does not have a complete income-statement cache yet.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. LRMR currently screens at market cap $204.9M.
Not investment advice. Open the KEY and LRMR stock pages for the full models.
Not investment advice.